JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors

Clinical trial NCT04280341 · UNKNOWN

Trial details

NCT number: NCT04280341
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-Positive Solid Tumors

Start date: 2020-06-03
Primary completion: 2024-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.